Steven Cohen’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-300,000
Closed -$5.4M – 4175
2026
Q2
$5.4M Hold
300,000
– – 0.01% 1704
2026
Q1
$5.51M Hold
300,000
– – 0.01% 1637
2025
Q4
$3.56M Buy
+300,000
New +$3.82M ﹤0.01% 2079
2018
Q4
– Sell
-1,850
Closed -$2.66M – 1059
2018
Q3
$2.66M Buy
1,850
+50
+3% +$75.6K 0.01% 718
2018
Q2
$2.9M Buy
1,800
+530
+42% +$911K 0.01% 712
2018
Q1
$2.06M Buy
+1,270
New +$2.64M 0.01% 730
2017
Q3
– Sell
-2,923
Closed -$3.26M – 940
2017
Q2
$3.26M Buy
+2,923
New +$2.41M 0.02% 569

Other funds holding CBIO

Steven Cohen's CBIO Position: Q3 2026 in Review

Steven Cohen sold out of Crescent Biopharma (CBIO) in Q3 2026, closing a stake of 300,000 shares — an estimated $5.4M sold.

Steven Cohen first reported a position in CBIO in Q2 2017 and held it in 7 quarters. The position peaked at $5.51M in Q1 2026. 106 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • Steven Cohen reported no remaining Crescent Biopharma position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 300,000 Crescent Biopharma shares in Q3 2026, an estimated $5.4M.
  • Steven Cohen first reported a position in Crescent Biopharma in Q2 2017 and held it in 7 quarters.
  • Steven Cohen's Crescent Biopharma position peaked at $5.51M in Q1 2026.
  • 106 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.